siRNA表达载体对SW480细胞原癌基因Pokemon的抑制

中国生物工程杂志

2009, Vol. 29

Issue (06): 7-13

技术与方法

siRNA表达载体对SW480细胞原癌基因Pokemon的抑制

郭睿,李喜霞,解军

山西医科大学生物化学与分子生物学教研室

Inhibition of Proto-oncogene Pokemon Expression by siRNA Expression Vector in SW480 Cells

全文: PDF(953 KB) HTML

摘要：

观察siRNA表达载体对SW480细胞中Pokemon原癌基因的抑制效应，为进一步研究该基因的功能奠定基础。构建针对Pokemon基因的RNAi质粒表达载体，脂质体法转染人结直肠癌SW480细胞系，观察转染效率及细胞表型变化。稳定转染后，实时荧光定量PCR和Western blot检测SW480细胞中Pokemon mRNA及蛋白质的表达情况；MTT法检测siRNA对SW480细胞恶性增殖的影响；流式细胞仪分析细胞凋亡改变。镜下观察阳性转染率约36%，转染表达载体后细胞形态发生了显著变化；Pokemon mRNA及蛋白质的表达受到明显抑制：与阴性对照组相比，表达质粒产生的siRNA对Pokemon mRNA的抑制率在转染后24 h和48 h分别为34.2%和67.7%；对蛋白的抑制率在48 h和72 h分别为48.3%和73.6%。MTT法检测细胞生长曲线表明Pokemon抑制可使SW480细胞生长速度明显减慢；流式细胞仪分析显示转染Pokemon siRNA表达质粒后SW480细胞凋亡增加。构建的RNAi表达载体可以有效抑制SW480细胞中Pokemon基因的表达，并对SW480细胞的生长具有明显抑制及诱导凋亡作用。

关键词： RNA干扰；Pokemon SW480；基因表达

Abstract:

Abstract To investigate the inhibitory effects of siRNA expression vector on proto-oncogene Pokemon expression in SW480 cells and to provide experimental basis for further research about the biological function of Pokemon. siRNA expression vectors were constructed to express a short hairpin RNA to Pokemon. The recombinants were transfected into SW480 cells with liposome. Cellular morphology and transfection efficiency were observed. The expression of Pokemon were checked by real-time fluorescence quantitative PCR and Western blot. The transfection efficiency was about 36% and the cellular morphology changed greatly at 24h after transfection. siRNA expression vectors could specific reduce the expression of Pokemon mRNA and protein in SW480 cells. Compared with negative control, the inhibition ratio of Pokemon mRNA expression was 67.7% and the inhibition ratio of Pokemon protein was 73.6% respectively. siRNA expression vectors were successfully established that could effectively inhibit the expression of Pokemon in SW480 cells.

Key words: RNAi Pokemon；SW480；gene expression

收稿日期: 2009-03-19 出版日期: 2009-07-02

ZTFLH:

Q819

基金资助:

精子发生相关新蛋白spata3

通讯作者: 解军 E-mail: xiejunty@yahoo.com

	服务
	把本文推荐给朋友
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	郭睿
	李喜霞
	解军

引用本文:

郭睿,李喜霞,解军. siRNA表达载体对SW480细胞原癌基因Pokemon的抑制[J]. 中国生物工程杂志, 2009, 29(06): 7-13.

GUO Rui, LI Chi-Xia, JIE Jun. Inhibition of Proto-oncogene Pokemon Expression by siRNA Expression Vector in SW480 Cells. China Biotechnology, 2009, 29(06): 7-13.

链接本文:

https://manu60.magtech.com.cn/biotech/CN/ 或 https://manu60.magtech.com.cn/biotech/CN/Y2009/V29/I06/7

［1］ Maeda T, Hobbs R M, Merghoub T, et al. Role of the protooncogene Pokemon in cellular transformation and ARF repression. Nature, 2005, 433 (7023): 278~285 ［2］ Maeda T, Hobbs R M, Pandolfi PP. The transcription factor Pokemon: a new key player in cancer pathogenesis. Cancer Res, 2005, 65 (19): 8575~8578 ［3］蔡思, 于永春. 特殊的原癌基因Pokemon. 国际外科学杂志, 2006, 33 (6): 464~467 Cai S, Yu Y C. International Journal of Surgery, 2006, 33 (6): 464~467 ［4］ Vorhies J S, Nemunaitis J J. Synthetic vs. natural/biodegradable polymers for delivery of shRNAbased cancer therapies. Methods Mol Biol, 2009, 480: 11~29 ［5］ Nakayashiki H, Nguyen Q B. RNA interference: roles in fungal biology. Curr Opin Microbiol, 2008, 11 (6): 494~502 ［6］ Kim D, Rossi J. RNAi mechanisms and applications. Biotechniques, 2008, 44 (5): 613~616 ［7］ Mine A, Okuno T. Viruses and RNA silencing. Uirusu, 2008, 58 (1): 61~68 ［8］ Dykxhoorn D M, Chowdhury D, Lieberman J. RNA interference and cancer: endogenous pathways and therapeutic approaches. Adv Ex PMed Biol, 2008, 615: 299~329 ［9］ Bernards R, Brummelkam PT R, Beijersbergen R L. shRNA libraries and their use in cancer genetics. Nat Methods, 2006, 3 (9): 701~706 ［10］Lu PY, Woodle M C. Delivering small interfering RNA for novel therapeutics. Methods Mol Biol, 2008, 437: 93~107 ［11］Stogios PJ, Chen L, Privé G G. Crystal structure of the BTB domain from the LRF/ZBTB7 transcriptional regulator. Protein Sci, 2007, 16 (2): 336~342 ［12］Agrawal A, Yang J, Murphy R F, et al. Regulation of the p14ARFMdm2p53 pathway: an overview in breast cancer. Ex PMol Pathol, 2006, 81 (2): 115~122 ［13］Jeon B N, Yoo J Y, Choi W I, et al. Protooncogene FBI1 (Pokemon/ZBTB7A) represses transcription of the tumor suppressor Rb gene via binding competition with Sp1 and recruitment of corepressors. J Biol Chem, 2008, 283 (48): 33199~33210 ［14］Brummelkam PT R, Bernards R, Agami R. A system for stable expression of short interfering RNAs in mammalian cells. Science, 2002, 296 (5567): 550~553 ［15］ Sui G, Soohoo C, Affarel B, et al. A DNA vectorbased RNAi technology to suppress gene expression in mammalian cells. Proc Natl Acad Sci, 2002, 99 (8): 5515~5520 ［16］ Rossi J J. Expression strategies for short hairpin RNA interference triggers. Hum Gene Ther, 2008, 19 (4): 313~317 ［17］Kim D R, Pushparaj PN, Aarthi J J, et al. siRNA, miRNA, and shRNA: in vivo applictions. J Dent Res, 2008, 87 (11): 992~1003

[1]	吴庆, 刘慧燕, 方海田, 何建国, 贺晓光, 于丽男, 王梦娇. 解淀粉芽孢杆菌高效合成胞苷的代谢调控机制及育种策略[J]. 中国生物工程杂志, 2015, 35(9): 122-127.
[2]	王洪苏, 关桂静, 刘金香. Alexa Fluor荧光标记在细胞学和分子生物学研究中的应用[J]. 中国生物工程杂志, 2015, 35(9): 71-77.
[3]	周立军, 刘文娟, 祁永浩, 李妙. SOCS3通过JNK和STAT3信号通路调控AKT[J]. 中国生物工程杂志, 2015, 35(9): 50-56.
[4]	梁高峰, 何向峰, 陈宝安. miRNA在肿瘤分子诊断和治疗中的研究进展[J]. 中国生物工程杂志, 2015, 35(9): 57-65.
[5]	尉研, 王焕琴, 吴萌, 张凤娟, 梁国栋, 朱武洋. 黄病毒检测工程细胞系的构建及功能鉴定[J]. 中国生物工程杂志, 2015, 35(9): 35-41.
[6]	赵央, 田海山, 李校堃, 姜潮. 成纤维细胞生长因子20研究进展[J]. 中国生物工程杂志, 2015, 35(8): 103-108.
[7]	李洪昌, 袁林, 张令强. *抑癌基因PTEN转基因小鼠的构建及表型初步分析*[J]. 中国生物工程杂志, 2015, 35(8): 1-8.
[8]	郭玮婷, 张慧, 查东风, 黄汉峰, 黄静, 高红亮, 常忠义, 金明飞, 鲁伟. 产耐高温谷氨酰胺转胺酶菌株的快速筛选方法[J]. 中国生物工程杂志, 2015, 35(8): 83-89.
[9]	康学军, 杨怡姝. HIV-1潜伏感染体外实验模型研究进展[J]. 中国生物工程杂志, 2015, 35(8): 96-102.
[10]	朱志坚, 连凯琪, 杨帆, 张伟, 郑海学, 杨孝朴. 稳定表达鼠源整联蛋白αvβ6的CHO-677细胞系的构建[J]. 中国生物工程杂志, 2015, 35(8): 23-29.
[11]	黄鹏, 李文姝, 谢君, 鲍建瑛, 曹晓娥, 余龙, 徐一新. 人源类溶菌酶蛋白6在毕赤酵母中的重组表达及活性分析[J]. 中国生物工程杂志, 2015, 35(8): 30-37.
[12]	任琴, 郭志鸿, 王亚军, 谢忠奎, 王若愚. RNA干扰及其在增强作物抵抗有害真核生物研究中的应用[J]. 中国生物工程杂志, 2015, 35(6): 80-89.
[13]	张超, 项丽娜, 陈德培, 吕鑫鑫, 赵宜桐, 王璐瑶, 肖健, 张宏宇. 碱性成纤维细胞生长因子促进神经损伤修复的研究进展[J]. 中国生物工程杂志, 2015, 35(6): 75-79.
[14]	贾翠丽, 张华伟, 王斌斌, 朱宏吉, 乔建军. 革兰氏阳性菌自然感受态生理机制的研究进展[J]. 中国生物工程杂志, 2015, 35(6): 90-100.
[15]	李佳鑫, 冯炜, 王志钢, 王彦凤. CRISPR/Cas9技术及其在转基因动物中的应用[J]. 中国生物工程杂志, 2015, 35(6): 109-115.

Viewed

Full text

Abstract

Cited

Shared

Discussed